Tweet
<img alt="" height="1" width="1" />
Biogen MS Pill With $3 Billion Potential Hits Study Goals
BusinessWeek
Oct. 26 (Bloomberg) -- Biogen Idec Inc., the world's largest maker of multiple sclerosis medicines, said its experimental MS pill BG-12 was safe and reduced the risk of patients relapsing in a second late-stage clinical trial. ...
Biogen MS drug BG-12 meets goal of second trialReuters
Biogen readies its app after BG-12 beats Copaxone in PhIII MS studyFierceBiotech
Biogen's MS Pill Wins AgainTheStreet.com
Genetic Engineering News -Globes -Financial News Network Online
all 32 news articles »
More...